Total: £ 56.28
Published Date: 2024-11-25 | Pages: 85 | Tables: 156 | New Technology
The global market for Soluble Microneedle Drug Delivery System was estimated to be worth US$ million in 2023 and is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during the forecast period 2024-2030.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Soluble Microneedle Drug Delivery System, focusing on the total sales revenue, key companies market share and ranking, together with an analysis of Soluble Microneedle Drug Delivery System by region & country, by Type, and by Application.
The Soluble Microneedle Drug Delivery System market size, estimations, and forecasts are provided in terms of sales revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. With both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Soluble Microneedle Drug Delivery System.
Market Segmentation
By Company
Corium
LG
Raphas
COSMED
Zhongke Microneedle
Excellent microorganisms
Qinglan Biology
Segment by Type:
Hydrogels
Polymer
Sugar
Segment by Application
Medicine
Vaccine
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
China Taiwan
Southeast Asia
India
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Chapter Outline
Chapter 1: Introduces the report scope of the report, global total market size. This chapter also provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 2: Detailed analysis of Soluble Microneedle Drug Delivery System manufacturers competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Revenue of Soluble Microneedle Drug Delivery System in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 6: Revenue of Soluble Microneedle Drug Delivery System in country level. It provides sigmate data by Type, and by Application for each country/region.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product revenue, gross margin, product introduction, recent development, etc.
Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 9: Conclusion.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Market Overview
1.1 Soluble Microneedle Drug Delivery System Product Introduction
1.2 Global Soluble Microneedle Drug Delivery System Market Size Forecast
1.3 Soluble Microneedle Drug Delivery System Market Trends & Drivers
1.3.1 Soluble Microneedle Drug Delivery System Industry Trends
1.3.2 Soluble Microneedle Drug Delivery System Market Drivers & Opportunity
1.3.3 Soluble Microneedle Drug Delivery System Market Challenges
1.3.4 Soluble Microneedle Drug Delivery System Market Restraints
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Competitive Analysis by Company
2.1 Global Soluble Microneedle Drug Delivery System Players Revenue Ranking (2023)
2.2 Global Soluble Microneedle Drug Delivery System Revenue by Company (2019-2024)
2.3 Key Companies Soluble Microneedle Drug Delivery System Manufacturing Base Distribution and Headquarters
2.4 Key Companies Soluble Microneedle Drug Delivery System Product Offered
2.5 Key Companies Time to Begin Mass Production of Soluble Microneedle Drug Delivery System
2.6 Soluble Microneedle Drug Delivery System Market Competitive Analysis
2.6.1 Soluble Microneedle Drug Delivery System Market Concentration Rate (2019-2024)
2.6.2 Global 5 and 10 Largest Companies by Soluble Microneedle Drug Delivery System Revenue in 2023
2.6.3 Global Top Companies by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soluble Microneedle Drug Delivery System as of 2023)
2.7 Mergers & Acquisitions, Expansion
3 Segmentation by Type
3.1 Introduction by Type
3.1.1 Hydrogels
3.1.2 Polymer
3.1.3 Sugar
3.2 Global Soluble Microneedle Drug Delivery System Sales Value by Type
3.2.1 Global Soluble Microneedle Drug Delivery System Sales Value by Type (2019 VS 2023 VS 2030)
3.2.2 Global Soluble Microneedle Drug Delivery System Sales Value, by Type (2019-2030)
3.2.3 Global Soluble Microneedle Drug Delivery System Sales Value, by Type (%) (2019-2030)
4 Segmentation by Application
4.1 Introduction by Application
4.1.1 Medicine
4.1.2 Vaccine
4.2 Global Soluble Microneedle Drug Delivery System Sales Value by Application
4.2.1 Global Soluble Microneedle Drug Delivery System Sales Value by Application (2019 VS 2023 VS 2030)
4.2.2 Global Soluble Microneedle Drug Delivery System Sales Value, by Application (2019-2030)
4.2.3 Global Soluble Microneedle Drug Delivery System Sales Value, by Application (%) (2019-2030)
5 Segmentation by Region
5.1 Global Soluble Microneedle Drug Delivery System Sales Value by Region
5.1.1 Global Soluble Microneedle Drug Delivery System Sales Value by Region: 2019 VS 2023 VS 2030
5.1.2 Global Soluble Microneedle Drug Delivery System Sales Value by Region (2019-2024)
5.1.3 Global Soluble Microneedle Drug Delivery System Sales Value by Region (2025-2030)
5.1.4 Global Soluble Microneedle Drug Delivery System Sales Value by Region (%), (2019-2030)
5.2 North America
5.2.1 North America Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
5.2.2 North America Soluble Microneedle Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.3 Europe
5.3.1 Europe Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
5.3.2 Europe Soluble Microneedle Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.4 Asia Pacific
5.4.1 Asia Pacific Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
5.4.2 Asia Pacific Soluble Microneedle Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.5 South America
5.5.1 South America Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
5.5.2 South America Soluble Microneedle Drug Delivery System Sales Value by Country (%), 2023 VS 2030
5.6 Middle East & Africa
5.6.1 Middle East & Africa Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
5.6.2 Middle East & Africa Soluble Microneedle Drug Delivery System Sales Value by Country (%), 2023 VS 2030
6 Segmentation by Key Countries/Regions
6.1 Key Countries/Regions Soluble Microneedle Drug Delivery System Sales Value Growth Trends, 2019 VS 2023 VS 2030
6.2 Key Countries/Regions Soluble Microneedle Drug Delivery System Sales Value
6.3 United States
6.3.1 United States Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
6.3.2 United States Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.3.3 United States Soluble Microneedle Drug Delivery System Sales Value by Application, 2023 VS 2030
6.4 Europe
6.4.1 Europe Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
6.4.2 Europe Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.4.3 Europe Soluble Microneedle Drug Delivery System Sales Value by Application, 2023 VS 2030
6.5 China
6.5.1 China Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
6.5.2 China Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.5.3 China Soluble Microneedle Drug Delivery System Sales Value by Application, 2023 VS 2030
6.6 Japan
6.6.1 Japan Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
6.6.2 Japan Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.6.3 Japan Soluble Microneedle Drug Delivery System Sales Value by Application, 2023 VS 2030
6.7 South Korea
6.7.1 South Korea Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
6.7.2 South Korea Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.7.3 South Korea Soluble Microneedle Drug Delivery System Sales Value by Application, 2023 VS 2030
6.8 Southeast Asia
6.8.1 Southeast Asia Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
6.8.2 Southeast Asia Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.8.3 Southeast Asia Soluble Microneedle Drug Delivery System Sales Value by Application, 2023 VS 2030
6.9 India
6.9.1 India Soluble Microneedle Drug Delivery System Sales Value, 2019-2030
6.9.2 India Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
6.9.3 India Soluble Microneedle Drug Delivery System Sales Value by Application, 2023 VS 2030
7 Company Profiles
7.1 Corium
7.1.1 Corium Profile
7.1.2 Corium Main Business
7.1.3 Corium Soluble Microneedle Drug Delivery System Products, Services and Solutions
7.1.4 Corium Soluble Microneedle Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.1.5 Corium Recent Developments
7.2 LG
7.2.1 LG Profile
7.2.2 LG Main Business
7.2.3 LG Soluble Microneedle Drug Delivery System Products, Services and Solutions
7.2.4 LG Soluble Microneedle Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.2.5 LG Recent Developments
7.3 Raphas
7.3.1 Raphas Profile
7.3.2 Raphas Main Business
7.3.3 Raphas Soluble Microneedle Drug Delivery System Products, Services and Solutions
7.3.4 Raphas Soluble Microneedle Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.3.5 COSMED Recent Developments
7.4 COSMED
7.4.1 COSMED Profile
7.4.2 COSMED Main Business
7.4.3 COSMED Soluble Microneedle Drug Delivery System Products, Services and Solutions
7.4.4 COSMED Soluble Microneedle Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.4.5 COSMED Recent Developments
7.5 Zhongke Microneedle
7.5.1 Zhongke Microneedle Profile
7.5.2 Zhongke Microneedle Main Business
7.5.3 Zhongke Microneedle Soluble Microneedle Drug Delivery System Products, Services and Solutions
7.5.4 Zhongke Microneedle Soluble Microneedle Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.5.5 Zhongke Microneedle Recent Developments
7.6 Excellent microorganisms
7.6.1 Excellent microorganisms Profile
7.6.2 Excellent microorganisms Main Business
7.6.3 Excellent microorganisms Soluble Microneedle Drug Delivery System Products, Services and Solutions
7.6.4 Excellent microorganisms Soluble Microneedle Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.6.5 Excellent microorganisms Recent Developments
7.7 Qinglan Biology
7.7.1 Qinglan Biology Profile
7.7.2 Qinglan Biology Main Business
7.7.3 Qinglan Biology Soluble Microneedle Drug Delivery System Products, Services and Solutions
7.7.4 Qinglan Biology Soluble Microneedle Drug Delivery System Revenue (US$ Million) & (2019-2024)
7.7.5 Qinglan Biology Recent Developments
8 Industry Chain Analysis
8.1 Soluble Microneedle Drug Delivery System Industrial Chain
8.2 Soluble Microneedle Drug Delivery System Upstream Analysis
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.2.3 Manufacturing Cost Structure
8.3 Midstream Analysis
8.4 Downstream Analysis (Customers Analysis)
8.5 Sales Model and Sales Channels
8.5.1 Soluble Microneedle Drug Delivery System Sales Model
8.5.2 Sales Channel
8.5.3 Soluble Microneedle Drug Delivery System Distributors
9 Research Findings and Conclusion
10 Appendix
10.1 Research Methodology
10.1.1 Methodology/Research Approach
10.1.2 Data Source
10.2 Author Details
10.3 Disclaimer
List of Tables
Table 1. Soluble Microneedle Drug Delivery System Market Trends
Table 2. Soluble Microneedle Drug Delivery System Market Drivers & Opportunity
Table 3. Soluble Microneedle Drug Delivery System Market Challenges
Table 4. Soluble Microneedle Drug Delivery System Market Restraints
Table 5. Global Soluble Microneedle Drug Delivery System Revenue by Company (2019-2024) & (US$ Million)
Table 6. Global Soluble Microneedle Drug Delivery System Revenue Market Share by Company (2019-2024)
Table 7. Key Companies Soluble Microneedle Drug Delivery System Manufacturing Base Distribution and Headquarters
Table 8. Key Companies Soluble Microneedle Drug Delivery System Product Type
Table 9. Key Companies Time to Begin Mass Production of Soluble Microneedle Drug Delivery System
Table 10. Global Soluble Microneedle Drug Delivery System Companies Market Concentration Ratio (CR5 and HHI)
Table 11. Global Top Companies Market Share by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Soluble Microneedle Drug Delivery System as of 2023)
Table 12. Mergers & Acquisitions, Expansion Plans
Table 13. Global Soluble Microneedle Drug Delivery System Sales Value by Type: 2019 VS 2023 VS 2030 (US$ Million)
Table 14. Global Soluble Microneedle Drug Delivery System Sales Value by Type (2019-2024) & (US$ Million)
Table 15. Global Soluble Microneedle Drug Delivery System Sales Value by Type (2025-2030) & (US$ Million)
Table 16. Global Soluble Microneedle Drug Delivery System Sales Market Share in Value by Type (2019-2024) & (%)
Table 17. Global Soluble Microneedle Drug Delivery System Sales Market Share in Value by Type (2025-2030) & (%)
Table 18. Global Soluble Microneedle Drug Delivery System Sales Value by Application: 2019 VS 2023 VS 2030 (US$ Million)
Table 19. Global Soluble Microneedle Drug Delivery System Sales Value by Application (2019-2024) & (US$ Million)
Table 20. Global Soluble Microneedle Drug Delivery System Sales Value by Application (2025-2030) & (US$ Million)
Table 21. Global Soluble Microneedle Drug Delivery System Sales Market Share in Value by Application (2019-2024) & (%)
Table 22. Global Soluble Microneedle Drug Delivery System Sales Market Share in Value by Application (2025-2030) & (%)
Table 23. Global Soluble Microneedle Drug Delivery System Sales Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
Table 24. Global Soluble Microneedle Drug Delivery System Sales Value by Region (2019-2024) & (US$ Million)
Table 25. Global Soluble Microneedle Drug Delivery System Sales Value by Region (2025-2030) & (US$ Million)
Table 26. Global Soluble Microneedle Drug Delivery System Sales Value by Region (2019-2024) & (%)
Table 27. Global Soluble Microneedle Drug Delivery System Sales Value by Region (2025-2030) & (%)
Table 28. Key Countries/Regions Soluble Microneedle Drug Delivery System Sales Value Growth Trends, (US$ Million): 2019 VS 2023 VS 2030
Table 29. Key Countries/Regions Soluble Microneedle Drug Delivery System Sales Value, (2019-2024) & (US$ Million)
Table 30. Key Countries/Regions Soluble Microneedle Drug Delivery System Sales Value, (2025-2030) & (US$ Million)
Table 31. Corium Basic Information List
Table 32. Corium Description and Business Overview
Table 33. Corium Soluble Microneedle Drug Delivery System Products, Services and Solutions
Table 34. Revenue (US$ Million) in Soluble Microneedle Drug Delivery System Business of Corium (2019-2024)
Table 35. Corium Recent Developments
Table 36. LG Basic Information List
Table 37. LG Description and Business Overview
Table 38. LG Soluble Microneedle Drug Delivery System Products, Services and Solutions
Table 39. Revenue (US$ Million) in Soluble Microneedle Drug Delivery System Business of LG (2019-2024)
Table 40. LG Recent Developments
Table 41. Raphas Basic Information List
Table 42. Raphas Description and Business Overview
Table 43. Raphas Soluble Microneedle Drug Delivery System Products, Services and Solutions
Table 44. Revenue (US$ Million) in Soluble Microneedle Drug Delivery System Business of Raphas (2019-2024)
Table 45. Raphas Recent Developments
Table 46. COSMED Basic Information List
Table 47. COSMED Description and Business Overview
Table 48. COSMED Soluble Microneedle Drug Delivery System Products, Services and Solutions
Table 49. Revenue (US$ Million) in Soluble Microneedle Drug Delivery System Business of COSMED (2019-2024)
Table 50. COSMED Recent Developments
Table 51. Zhongke Microneedle Basic Information List
Table 52. Zhongke Microneedle Description and Business Overview
Table 53. Zhongke Microneedle Soluble Microneedle Drug Delivery System Products, Services and Solutions
Table 54. Revenue (US$ Million) in Soluble Microneedle Drug Delivery System Business of Zhongke Microneedle (2019-2024)
Table 55. Zhongke Microneedle Recent Developments
Table 56. Excellent microorganisms Basic Information List
Table 57. Excellent microorganisms Description and Business Overview
Table 58. Excellent microorganisms Soluble Microneedle Drug Delivery System Products, Services and Solutions
Table 59. Revenue (US$ Million) in Soluble Microneedle Drug Delivery System Business of Excellent microorganisms (2019-2024)
Table 60. Excellent microorganisms Recent Developments
Table 61. Qinglan Biology Basic Information List
Table 62. Qinglan Biology Description and Business Overview
Table 63. Qinglan Biology Soluble Microneedle Drug Delivery System Products, Services and Solutions
Table 64. Revenue (US$ Million) in Soluble Microneedle Drug Delivery System Business of Qinglan Biology (2019-2024)
Table 65. Qinglan Biology Recent Developments
Table 66. Key Raw Materials Lists
Table 67. Raw Materials Key Suppliers Lists
Table 68. Soluble Microneedle Drug Delivery System Downstream Customers
Table 69. Soluble Microneedle Drug Delivery System Distributors List
Table 70. Research Programs/Design for This Report
Table 71. Key Data Information from Secondary Sources
Table 72. Key Data Information from Primary Sources
Table 73. Business Unit and Senior & Team Lead Analysts
List of Figures
Figure 1. Soluble Microneedle Drug Delivery System Product Picture
Figure 2. Global Soluble Microneedle Drug Delivery System Sales Value, 2019 VS 2023 VS 2030 (US$ Million)
Figure 3. Global Soluble Microneedle Drug Delivery System Sales Value (2019-2030) & (US$ Million)
Figure 4. Soluble Microneedle Drug Delivery System Report Years Considered
Figure 5. Global Soluble Microneedle Drug Delivery System Players Revenue Ranking (2023) & (US$ Million)
Figure 6. The 5 and 10 Largest Manufacturers in the World: Market Share by Soluble Microneedle Drug Delivery System Revenue in 2023
Figure 7. Soluble Microneedle Drug Delivery System Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
Figure 8. Hydrogels Picture
Figure 9. Polymer Picture
Figure 10. Sugar Picture
Figure 11. Global Soluble Microneedle Drug Delivery System Sales Value by Type (2019 VS 2023 VS 2030) & (US$ Million)
Figure 12. Global Soluble Microneedle Drug Delivery System Sales Value Market Share by Type, 2023 & 2030
Figure 13. Product Picture of Medicine
Figure 14. Product Picture of Vaccine
Figure 15. Global Soluble Microneedle Drug Delivery System Sales Value by Application (2019 VS 2023 VS 2030) & (US$ Million)
Figure 16. Global Soluble Microneedle Drug Delivery System Sales Value Market Share by Application, 2023 & 2030
Figure 17. North America Soluble Microneedle Drug Delivery System Sales Value (2019-2030) & (US$ Million)
Figure 18. North America Soluble Microneedle Drug Delivery System Sales Value by Country (%), 2023 VS 2030
Figure 19. Europe Soluble Microneedle Drug Delivery System Sales Value (2019-2030) & (US$ Million)
Figure 20. Europe Soluble Microneedle Drug Delivery System Sales Value by Country (%), 2023 VS 2030
Figure 21. Asia Pacific Soluble Microneedle Drug Delivery System Sales Value (2019-2030) & (US$ Million)
Figure 22. Asia Pacific Soluble Microneedle Drug Delivery System Sales Value by Country (%), 2023 VS 2030
Figure 23. South America Soluble Microneedle Drug Delivery System Sales Value (2019-2030) & (US$ Million)
Figure 24. South America Soluble Microneedle Drug Delivery System Sales Value by Country (%), 2023 VS 2030
Figure 25. Middle East & Africa Soluble Microneedle Drug Delivery System Sales Value (2019-2030) & (US$ Million)
Figure 26. Middle East & Africa Soluble Microneedle Drug Delivery System Sales Value by Country (%), 2023 VS 2030
Figure 27. Key Countries/Regions Soluble Microneedle Drug Delivery System Sales Value (%), (2019-2030)
Figure 28. United States Soluble Microneedle Drug Delivery System Sales Value, (2019-2030) & (US$ Million)
Figure 29. United States Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
Figure 30. United States Soluble Microneedle Drug Delivery System Sales Value by Application (%), 2023 VS 2030
Figure 31. Europe Soluble Microneedle Drug Delivery System Sales Value, (2019-2030) & (US$ Million)
Figure 32. Europe Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
Figure 33. Europe Soluble Microneedle Drug Delivery System Sales Value by Application (%), 2023 VS 2030
Figure 34. China Soluble Microneedle Drug Delivery System Sales Value, (2019-2030) & (US$ Million)
Figure 35. China Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
Figure 36. China Soluble Microneedle Drug Delivery System Sales Value by Application (%), 2023 VS 2030
Figure 37. Japan Soluble Microneedle Drug Delivery System Sales Value, (2019-2030) & (US$ Million)
Figure 38. Japan Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
Figure 39. Japan Soluble Microneedle Drug Delivery System Sales Value by Application (%), 2023 VS 2030
Figure 40. South Korea Soluble Microneedle Drug Delivery System Sales Value, (2019-2030) & (US$ Million)
Figure 41. South Korea Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
Figure 42. South Korea Soluble Microneedle Drug Delivery System Sales Value by Application (%), 2023 VS 2030
Figure 43. Southeast Asia Soluble Microneedle Drug Delivery System Sales Value, (2019-2030) & (US$ Million)
Figure 44. Southeast Asia Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
Figure 45. Southeast Asia Soluble Microneedle Drug Delivery System Sales Value by Application (%), 2023 VS 2030
Figure 46. India Soluble Microneedle Drug Delivery System Sales Value, (2019-2030) & (US$ Million)
Figure 47. India Soluble Microneedle Drug Delivery System Sales Value by Type (%), 2023 VS 2030
Figure 48. India Soluble Microneedle Drug Delivery System Sales Value by Application (%), 2023 VS 2030
Figure 49. Soluble Microneedle Drug Delivery System Industrial Chain
Figure 50. Soluble Microneedle Drug Delivery System Manufacturing Cost Structure
Figure 51. Channels of Distribution (Direct Sales, and Distribution)
Figure 52. Bottom-up and Top-down Approaches for This Report
Figure 53. Data Triangulation